title: Adalimumab induction for Crohn's disease.
authors.forename: Mario
authors.initials: M
authors.lastname: Cottone
authors.forename: Filippo
authors.initials: F
authors.lastname: Mocciaro
authors.forename: Daniela
authors.initials: D
authors.lastname: Scimeca
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000175:diagnosis* / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D012016:Reference Values; D012074:Remission Induction; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab